Primary Colour:
Primary Text:
Secondary Colour:
Secondary Text:
Tertiary Colour:
Tertiary Text:
Colour Picker
Preview
FeaturesTypographyTutorials
Module Title
Home
Module Title

This block of text is used as an example for the colour chooser module on this web site. This paragraph is functionally unimportant, and can safely be ignored.

Module Title
Module Title
Instructions

Select a predefined style from the drop-down or choose your own colours via the handy colour-chooser. When you are satisfied with your selection, click the "Apply Colours" button below to store your selection in a cookie.

Apply Colours

Holyrood opinion poll

With the publication of the interim Calman Report, do you think –
 
Home arrow Holyrood news arrow News categories arrow Health & Wellbeing (HCL07) arrow University showcases medical advances
University showcases medical advances Print E-mail
Wednesday, 20 June 2007

An exhibition showcasing new drug discoveries, including technology to prevent MRSA infection, an oral vaccine to replace injections and a marigold-based treatment for psoriasis, will open today in Glasgow.

The research, developed by scientists at the University of Strathclyde’s Institute of Pharmacy and Biomedical Sciences, includes a new method of controlling bacterial infections such as MRSA by embedding bacteriophages – naturally occurring viruses that prey on bacteria - into physical materials, such as cotton, silk and polythene, to prevent the ‘superbug’ infection.

Other discoveries include a new treatment for the skin condition psoriasis, which affects around three percent of the population in Europe and North America, and a drinkable influenza vaccine, which could replace the traditional injection.

Anne Muir, business development manager at the Faculty of Science, said: "The Institute is working on leading-edge research and technology to tackle the diseases of the 21st Century. We are delighted to be welcoming representatives from companies across the UK to view our developments.

"Strathclyde has a proud record of drug discovery and development. We are committed to working closely with industry to help ensure our research is translated into products that benefit patients."
No one has commented on this article.
The author or administrator has closed this item for comments.


Related news items:
Last Updated ( Wednesday, 20 June 2007 )
 
[ Back ]

Featured sites

Site news...


Holyrood.com has received a facelift, to coincide with the last magazine of the season.

Along with the new template, we've also launched a forum for registered users.

Please feel free to This e-mail address is being protected from spam bots, you need JavaScript enabled to view it


 
Visitors: 6523622